1	3	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	aim	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	study	_	_	NN	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	elucidate	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	rMnSOD-dependent	_	_	JJ	_	_	_	_	_
11	nSMase	_	_	NN	_	_	_	_	_
12	changes	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	their	_	_	PRP$	_	_	_	_	_
15	role	_	_	NN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	protective-preventive	_	_	JJ	_	_	_	_	_
19	effect	_	_	NN	_	_	_	_	_
20	from	_	_	IN	_	_	_	_	_
21	ionizing	_	_	VBG	_	_	_	_	_
22	radiation	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	brain	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Mice	_	_	NNS	_	_	_	_	_
2	were	_	_	VBD	_	_	_	_	_
3	exposed	_	_	VBN	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	set	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	minor	_	_	JJ	_	_	_	_	_
9	γ	_	_	NN	_	_	_	_	_
10	radiation	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	neutrons	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	spectrum	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	neutrons	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	simulating	_	_	VBG	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	radiation	_	_	NN	_	_	_	_	_
22	levels	_	_	NNS	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	which	_	_	WDT	_	_	_	_	_
25	cosmonauts	_	_	NNS	_	_	_	_	_
26	will	_	_	MD	_	_	_	_	_
27	be	_	_	VB	_	_	_	_	_
28	exposed	_	_	VBN	_	_	_	_	_
29	during	_	_	IN	_	_	_	_	_
30	deep-space	_	_	JJ	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	long-term	_	_	JJ	_	_	_	_	_
33	missions	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	At	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	moment	_	_	NN	_	_	_	_	_
4	we	_	_	PRP	_	_	_	_	_
5	do	_	_	VBP	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	know	_	_	VB	_	_	_	_	_
8	whether	_	_	IN	_	_	_	_	_
9	γ	_	_	NN	_	_	_	_	_
10	radiation	_	_	NN	_	_	_	_	_
11	only	_	_	RB	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	unable	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	induce	_	_	VB	_	_	_	_	_
16	nSMase	_	_	NN	_	_	_	_	_
17	activation	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	show	_	_	VBP	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	rMnSOD	_	_	NN	_	_	_	_	_
5	particles	_	_	NNS	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	capable	_	_	JJ	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	cross	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	blood-brain	_	_	NN	_	_	_	_	_
12	barrier	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	localize	_	_	VB	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	midbrain	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	rMnSOD	_	_	NNP	_	_	_	_	_
4	has	_	_	VBZ	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	ability	_	_	NN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	limit	_	_	VB	_	_	_	_	_
9	radiation-induced	_	_	JJ	_	_	_	_	_
10	damage	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	such	_	_	JJ	_	_	_	_	_
13	as	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	loss	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	neuron	_	_	NN	_	_	_	_	_
18	number	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	alteration	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	neurofilaments	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	effect	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	radiation	_	_	NN	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	brain	_	_	NN	_	_	_	_	_
7	damage	_	_	NN	_	_	_	_	_
8	has	_	_	VBZ	_	_	_	_	_
9	previously	_	_	RB	_	_	_	_	_
10	been	_	_	VBN	_	_	_	_	_
11	reported	_	_	VBN	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	other	_	_	JJ	_	_	_	_	_
14	authors	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	many	_	_	JJ	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	elucidated	_	_	VBD	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	radioprotective	_	_	JJ	_	_	_	_	_
7	role	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	rMnSOD	_	_	NN	_	_	_	_	_
10	through	_	_	IN	_	_	_	_	_
11	antioxidant	_	_	JJ	_	_	_	_	_
12	mechanisms	_	_	NNS	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	mitochondria	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	no	_	_	DT	_	_	_	_	_
17	data	_	_	NNS	_	_	_	_	_
18	exist	_	_	VBP	_	_	_	_	_
19	about	_	_	IN	_	_	_	_	_
20	its	_	_	PRP$	_	_	_	_	_
21	effect	_	_	NN	_	_	_	_	_
22	on	_	_	IN	_	_	_	_	_
23	nSMase	_	_	NNP	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	show	_	_	VBP	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	rMnSOD	_	_	NNP	_	_	_	_	_
5	stimulates	_	_	VBZ	_	_	_	_	_
6	nSMase	_	_	NN	_	_	_	_	_
7	gene	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	protein	_	_	NN	_	_	_	_	_
10	expression	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	enzymatic	_	_	JJ	_	_	_	_	_
13	activity	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	was	_	_	VBD	_	_	_	_	_
4	articulated	_	_	VBN	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	aim	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	analyzing	_	_	VBG	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	response	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	nSMase	_	_	NNP	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	samples	_	_	NNS	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	which	_	_	WDT	_	_	_	_	_
18	rMnSOD	_	_	NNP	_	_	_	_	_
19	has	_	_	VBZ	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	protective	_	_	JJ	_	_	_	_	_
22	effect	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	non-pretreated	_	_	JJ	_	_	_	_	_
25	samples	_	_	NNS	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	samples	_	_	NNS	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	which	_	_	WDT	_	_	_	_	_
32	rMnSOD	_	_	NNP	_	_	_	_	_
33	has	_	_	VBZ	_	_	_	_	_
34	a	_	_	DT	_	_	_	_	_
35	preventive	_	_	JJ	_	_	_	_	_
36	effect	_	_	NN	_	_	_	_	_
37	(	_	_	-LRB-	_	_	_	_	_
38	pretreated	_	_	VBN	_	_	_	_	_
39	samples	_	_	NNS	_	_	_	_	_
40	)	_	_	-RRB-	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	samples	_	_	NNS	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	protective	_	_	JJ	_	_	_	_	_
5	effect	_	_	NN	_	_	_	_	_
6	study	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	rMnSOD	_	_	NNP	_	_	_	_	_
9	increases	_	_	VBZ	_	_	_	_	_
10	strongly	_	_	RB	_	_	_	_	_
11	nSMase	_	_	NN	_	_	_	_	_
12	gene	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	protein	_	_	NN	_	_	_	_	_
15	expression	_	_	NN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	irradiated	_	_	VBN	_	_	_	_	_
18	samples	_	_	NNS	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	dose-dependent	_	_	JJ	_	_	_	_	_
22	manner	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Small	_	_	JJ	_	_	_	_	_
2	variations	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	nSMase	_	_	NN	_	_	_	_	_
5	enzyme	_	_	NN	_	_	_	_	_
6	activities	_	_	NNS	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	obtained	_	_	VBN	_	_	_	_	_
9	only	_	_	RB	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	high	_	_	JJ	_	_	_	_	_
12	radiation	_	_	NN	_	_	_	_	_
13	doses	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	observation	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	relevant	_	_	JJ	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	nSMase	_	_	NNP	_	_	_	_	_
8	plays	_	_	VBZ	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	crucial	_	_	JJ	_	_	_	_	_
11	role	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	regulation	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	ROS	_	_	NNPS	_	_	_	_	_
17	generation	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	maintenance	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	homeostasis	_	_	NN	_	_	_	_	_
24	between	_	_	IN	_	_	_	_	_
25	proapoptotic	_	_	JJ	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	prosurvival	_	_	JJ	_	_	_	_	_
28	signals	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	line	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	we	_	_	PRP	_	_	_	_	_
7	show	_	_	VBP	_	_	_	_	_
8	that	_	_	IN	_	_	_	_	_
9	highest	_	_	JJS	_	_	_	_	_
10	radiation	_	_	NN	_	_	_	_	_
11	levels	_	_	NNS	_	_	_	_	_
12	induce	_	_	VBP	_	_	_	_	_
13	significant	_	_	JJ	_	_	_	_	_
14	nSMase	_	_	NN	_	_	_	_	_
15	responses	_	_	NNS	_	_	_	_	_
16	only	_	_	RB	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	presence	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	rMnSOD	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	present	_	_	JJ	_	_	_	_	_
4	results	_	_	NNS	_	_	_	_	_
5	indicate	_	_	VBP	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	nSMase	_	_	NNP	_	_	_	_	_
8	may	_	_	MD	_	_	_	_	_
9	be	_	_	VB	_	_	_	_	_
10	required	_	_	VBN	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	action	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	rMnSOD	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	we	_	_	PRP	_	_	_	_	_
18	cannot	_	_	MD	_	_	_	_	_
19	prove	_	_	VB	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	direct	_	_	JJ	_	_	_	_	_
22	action	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	rMnSOD	_	_	NN	_	_	_	_	_
25	on	_	_	IN	_	_	_	_	_
26	this	_	_	DT	_	_	_	_	_
27	enzyme	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	our	_	_	PRP$	_	_	_	_	_
3	knowledge	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	this	_	_	DT	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	first	_	_	JJ	_	_	_	_	_
9	study	_	_	NN	_	_	_	_	_
10	indicating	_	_	VBG	_	_	_	_	_
11	SMase	_	_	NNP	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	potential	_	_	JJ	_	_	_	_	_
15	effector	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	rMnSOD	_	_	NN	_	_	_	_	_
18	during	_	_	IN	_	_	_	_	_
19	its	_	_	PRP$	_	_	_	_	_
20	protection	_	_	NN	_	_	_	_	_
21	action	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	samples	_	_	NNS	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	preventive	_	_	JJ	_	_	_	_	_
5	effect	_	_	NN	_	_	_	_	_
6	study	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	nSMase	_	_	NNP	_	_	_	_	_
9	gene	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	protein	_	_	NN	_	_	_	_	_
12	expression	_	_	NN	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	reduced	_	_	VBN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	comparison	_	_	NN	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	samples	_	_	NNS	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	which	_	_	WDT	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	protective	_	_	JJ	_	_	_	_	_
24	effect	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	rMnSOD	_	_	NN	_	_	_	_	_
27	is	_	_	VBZ	_	_	_	_	_
28	studied	_	_	VBN	_	_	_	_	_
29	but	_	_	CC	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	enzyme	_	_	NN	_	_	_	_	_
32	activity	_	_	NN	_	_	_	_	_
33	is	_	_	VBZ	_	_	_	_	_
34	much	_	_	RB	_	_	_	_	_
35	higher	_	_	JJR	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	At	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	moment	_	_	NN	_	_	_	_	_
4	we	_	_	PRP	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	only	_	_	RB	_	_	_	_	_
7	speculate	_	_	VB	_	_	_	_	_
8	why	_	_	WRB	_	_	_	_	_
9	nSMase	_	_	NNP	_	_	_	_	_
10	levels	_	_	NNS	_	_	_	_	_
11	are	_	_	VBP	_	_	_	_	_
12	reduced	_	_	VBN	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	pretreatment	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	possible	_	_	JJ	_	_	_	_	_
18	explanation	_	_	NN	_	_	_	_	_
19	being	_	_	VBG	_	_	_	_	_
20	that	_	_	IN	_	_	_	_	_
21	an	_	_	DT	_	_	_	_	_
22	extended	_	_	JJ	_	_	_	_	_
23	treatment	_	_	NN	_	_	_	_	_
24	time	_	_	NN	_	_	_	_	_
25	could	_	_	MD	_	_	_	_	_
26	stimulate	_	_	VB	_	_	_	_	_
27	different	_	_	JJ	_	_	_	_	_
28	metabolic	_	_	JJ	_	_	_	_	_
29	patterns	_	_	NNS	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	leading	_	_	VBG	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	inhibition	_	_	NN	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	nSMase	_	_	NN	_	_	_	_	_
36	gene	_	_	NN	_	_	_	_	_
37	expression	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	Merging	_	_	VBG	_	_	_	_	_
2	already	_	_	RB	_	_	_	_	_
3	published	_	_	VBN	_	_	_	_	_
4	data	_	_	NNS	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	our	_	_	PRP$	_	_	_	_	_
7	findings	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	it	_	_	PRP	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	possible	_	_	JJ	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	suggest	_	_	VB	_	_	_	_	_
14	that	_	_	IN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	brain	_	_	NN	_	_	_	_	_
17	tissues	_	_	NNS	_	_	_	_	_
18	exposed	_	_	VBN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	radiation	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	significant	_	_	JJ	_	_	_	_	_
23	amounts	_	_	NNS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	ROS	_	_	NNPS	_	_	_	_	_
26	are	_	_	VBP	_	_	_	_	_
27	generated	_	_	VBN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	stimulating	_	_	VBG	_	_	_	_	_
30	nSMase	_	_	NN	_	_	_	_	_
31	production	_	_	NN	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	significantly	_	_	RB	_	_	_	_	_
34	increase	_	_	VB	_	_	_	_	_
35	MnSOD	_	_	NN	_	_	_	_	_
36	levels	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	may	_	_	MD	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	turn	_	_	NN	_	_	_	_	_
5	stimulate	_	_	VB	_	_	_	_	_
6	nSMase	_	_	NNP	_	_	_	_	_
7	.	_	_	.	_	_	_	_	_


1	At	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	point	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	ROS	_	_	NNP	_	_	_	_	_
6	levels	_	_	NNS	_	_	_	_	_
7	may	_	_	MD	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	reduced	_	_	VBN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	end	_	_	NN	_	_	_	_	_
14	result	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	limiting	_	_	VBG	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	damage	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	above	_	_	JJ	_	_	_	_	_
4	described	_	_	VBN	_	_	_	_	_
5	series	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	events	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	nSMase	_	_	NNP	_	_	_	_	_
10	may	_	_	MD	_	_	_	_	_
11	play	_	_	VB	_	_	_	_	_
12	predominant	_	_	JJ	_	_	_	_	_
13	roles	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_

